Explanation
Upto30ofpatientsmayexperiencearseinbloodpressur
Erythropoietin isasafeandeffectivemeansofmaintaininahaemoqlobin inpatientswhoareiron-replete wth
chronickidnevdisease.Therearethreemaiorpreparations;Epoietin-aepoietin-Banddarbepoietin.
Ervthropoietin isaivensubcutaneousorintravenousv: epoietin-aandEpoietin-Barecuinicalv
indistinauishableandusualv aiven subcutaneoust
-3tmes per week;darbepoeitinhas alonqer half-lffe,so
isadministered weekl,fortniahtty ormontht.Theblood pressure,haemoqlobin andreticulocytecountshould
bemonitoredregularty.every 2weeksor monthtyFailuretorespond maysuqqestundertyina coexistentiron
deficiencv.bleeding,malignancy or infection.
Disadvantaqesincludethecostandariseinblood pressureinupto30%ofpatients.particularty duringthe
first6months.Thereisariseinperipheralvascularresistanceduetoadecrease inhvpoxicvasodilatationand
an increaseinblood viscositv.Encephalopathvisararecompuicationthatresuts inftsandtransientcorticat
blindness.
@1MIN ENDOCRINE
